{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-26-000031","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2026-07-22T21:07:10+00:00","discovered_at":"2026-07-22T21:08:00.317390+00:00","generated_at":"2026-07-22T21:08:05.766045+00:00","sec_items":["2.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Supernus to report Q2 2026 results on August 4, 2026","bullets":["Earnings release after market close on Tuesday, August 4, 2026.","Conference call at 4:30 p.m. ET that day; webcast replay available for 60 days.","No preliminary financial results or guidance provided in this announcement."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-26-000031","json":"https://secwatch.observer/filing/0001356576-26-000031.json","markdown":"https://secwatch.observer/filing/0001356576-26-000031.md","text":"https://secwatch.observer/filing/0001356576-26-000031.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000031/0001356576-26-000031-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657626000031/supn-20260722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-22T21:08:05.766045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}